$MPT earnings report

MPT reported third-quarter net income of $202 million ($0.34 per share) and Normalized Funds from Operations of $64 million ($0.11 per share), while completing approximately $680 million of asset sales and a private offering of approximately $2.4 billion of secured notes. AlphAI read Medical Properties Trust's third quarter 2026 filing as mixed. 2 quarters are on record below.

third quarter 2026

AlphAI · Earnings readMPT · third quarter 2026 · ended September 30, 2026

MPT reported third-quarter net income of $202 million ($0.34 per share) and Normalized Funds from Operations of $64 million ($0.11 per share), while completing approximately $680 million of asset sales and a private offering of approximately $2.4 billion of secured notes.

→Mixed quarter

GAAP results swung to net income on real-estate sale gains and a debt-refinancing benefit, but NFFO declined to $64 million from $77 million and HSA's missed September rent reduced quarterly NFFO by two cents per share.

Revenue
$250M
EPS · non-GAAP
$0.24

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Total revenues, three months ended September 30, 2026GAAP$250.1M––
Rent billed, three months ended September 30, 2026GAAP$195.3M––
Straight-line rent, three months ended September 30, 2026GAAP$35.70M––
Income from financing leases, three months ended September 30, 2026GAAP$10.10M––
Interest and other income, three months ended September 30, 2026GAAP$9.04M––
Total expenses, three months ended September 30, 2026GAAP$263.9M––
Interest expense, three months ended September 30, 2026GAAP$153.1M––
Real estate depreciation and amortization, three months ended September 30, 2026GAAP$70.34M––
Property-related expense, three months ended September 30, 2026GAAP$11.40M––
General and administrative expense, three months ended September 30, 2026GAAP$29.04M––
Gain (loss) on sale of real estate, three months ended September 30, 2026GAAP$157.8M––
Real estate and other impairment charges, net, three months ended September 30, 2026GAAP($23,870) (Amounts in thousands)––
Earnings from equity interests, three months ended September 30, 2026GAAP$6.99M––
Debt refinancing and unutilized financing benefit (costs), three months ended September 30, 2026GAAP$69.52M––
Other (including fair value adjustments on securities), three months ended September 30, 2026GAAP$15.42M––
Net income, three months ended September 30, 2026GAAP$202.1M––
Net income attributable to MPT common stockholders, three months ended September 30, 2026GAAP$201.6M––
Net income attributable to MPT common stockholders per common share, basic and diluted, three months ended September 30, 2026GAAP$0.34––
Funds from operations, three months ended September 30, 2026non-GAAP$143.4M––
Funds from operations per diluted share, three months ended September 30, 2026non-GAAP$0.24––
Normalized funds from operations, three months ended September 30, 2026non-GAAP$63.82M––
Normalized funds from operations per diluted share, three months ended September 30, 2026non-GAAP$0.11––
Total revenues, nine months ended September 30, 2026GAAP$761.5M––
Rent billed, nine months ended September 30, 2026GAAP$596.2M––
Straight-line rent, nine months ended September 30, 2026GAAP$103.2M––
Income from financing leases, nine months ended September 30, 2026GAAP$30.24M––
Interest and other income, nine months ended September 30, 2026GAAP$31.82M––
Total expenses, nine months ended September 30, 2026GAAP$759.7M––
Gain (loss) on sale of real estate, nine months ended September 30, 2026GAAP$163.4M––
Net income (loss), nine months ended September 30, 2026GAAP$232.9M––
Net income (loss) attributable to MPT common stockholders per common share, basic and diluted, nine months ended September 30, 2026GAAP$0.39––
Normalized funds from operations, nine months ended September 30, 2026non-GAAP$238.3M––
Normalized funds from operations per diluted share, nine months ended September 30, 2026non-GAAP$0.40––

Amounts quoted below without a unit are in thousands, as in the filing’s tables. Per-share figures are as printed.

2027 outlook

  • NotePortfolio cash rents in excess of $1.0 billion in 2027, even after reduction of the rental income associated with assets sold in the third quarter.

Capital returns

  • Paid a regular quarterly dividend of $0.09 per share in October 2026.
  • Dividends declared per common share were $0.09 for the three months ended September 30, 2026, compared to $0.08 for the three months ended September 30, 2025.
  • Dividends declared per common share were $0.27 for the nine months ended September 30, 2026, compared to $0.24 for the nine months ended September 30, 2025.

What drove it

  • The Company sold its remaining interest in five hospitals in Utah for approximately $174 million.
  • The Company sold its interest in the real estate of two hospitals in Idaho to affiliates of Intermountain Health for approximately $371 million.
  • The private offering of approximately $2.4 billion of secured notes generated a $70 million gain in the quarter through repayment of existing debt.
  • Rent billed was $195,305 (Amounts in thousands) in the third quarter, compared with $181,001 (Amounts in thousands) in the year-earlier period.
  • General and administrative expense was $29,036 (Amounts in thousands), compared with $37,734 (Amounts in thousands) in the year-earlier period.

Concerns

  • HSA did not pay September rent because of continued revenue cycle management challenges, reducing quarterly NFFO by two cents per share.
  • MPT provided HSA additional working capital support during the quarter.
  • Interest expense was $153,091 (Amounts in thousands) in the third quarter, compared with $132,395 (Amounts in thousands) in the year-earlier period.
  • Earnings from equity interests were $6,988 (Amounts in thousands), compared with $34,403 (Amounts in thousands) in the year-earlier period.
  • NFFO was $63,816 (Amounts in thousands), compared with $77,213 (Amounts in thousands) in the year-earlier period.

What to watch

  • HSA's billings and collections after its engagement of Ovation Healthcare to oversee operations across the portfolio.
  • Whether portfolio cash rents exceed $1.0 billion in 2027, including the Company's conservative assumptions for cash-basis tenants and HSA.
  • Further debt repayment and balance-sheet improvement using the approximately $680 million of third-quarter asset-sale proceeds.
  • The timing and execution of the Company's objective to further reduce debt and pursue selective growth opportunities.

Balance sheet and cash flow

  • Cash and cash equivalents were $599,282 (Amounts in thousands) as of September 30, 2026, compared with $540,859 (Amounts in thousands) as of December 31, 2025.
  • Debt, net was $9,260,257 (Amounts in thousands) as of September 30, 2026, compared with $9,697,835 (Amounts in thousands) as of December 31, 2025.
  • Total Assets were $14,393,696 (Amounts in thousands) as of September 30, 2026, compared with $15,001,775 (Amounts in thousands) as of December 31, 2025.
  • Total Liabilities were $9,771,270 (Amounts in thousands) as of September 30, 2026, compared with $10,394,526 (Amounts in thousands) as of December 31, 2025.
  • Completed a private offering of approximately $2.4 billion of secured notes, with proceeds used to repay existing debt, including the 2026 notes and approximately 50% of the 2027 notes.
  • Completed sales of certain assets resulting in approximately $680 million in cash proceeds in the third quarter, representing an aggregate $158 million gain.

Analysis

Third-quarter GAAP earnings improved materially from the year-earlier loss. Net income was $202,077 (Amounts in thousands), or $0.34 per common share, versus a loss of $77,450 (Amounts in thousands), or ($0.13) per common share. The result was driven by $157,766 (Amounts in thousands) of gain on sale of real estate and a $69,524 (Amounts in thousands) debt refinancing and unutilized financing benefit, compared with a $9,115 (Amounts in thousands) loss on sale and $14 (Amounts in thousands) of refinancing costs in the prior-year period.

Underlying supplemental earnings moved in the opposite direction. NFFO was $63,816 (Amounts in thousands), or $0.11 per diluted share, down from $77,213 (Amounts in thousands), or $0.13 per diluted share. Management stated that HSA's unpaid September rent reduced quarterly NFFO by two cents per share. Rent billed was $195,305 (Amounts in thousands), above $181,001 (Amounts in thousands) a year earlier, but straight-line rent was $35,699 (Amounts in thousands), below $36,405 (Amounts in thousands), while interest expense increased to $153,091 (Amounts in thousands) from $132,395 (Amounts in thousands).

Capital recycling and debt management dominated the quarter. MPT completed approximately $680 million of asset sales for an aggregate $158 million gain, including approximately $174 million from five Utah hospitals and approximately $371 million from two Idaho hospitals. It also completed a private offering of approximately $2.4 billion of secured notes to repay existing debt, including the 2026 notes and approximately 50% of the 2027 notes. Cash and cash equivalents were $599,282 (Amounts in thousands) and debt, net was $9,260,257 (Amounts in thousands) at September 30, 2026, versus $540,859 (Amounts in thousands) and $9,697,835 (Amounts in thousands), respectively, at December 31, 2025.

Portfolio scale at quarter end was 365 properties and approximately 37,000 licensed beds leased to or mortgaged by 52 hospital operating companies. MPT reported total assets of approximately $14.4 billion, including $8.3 billion of general acute facilities, $2.4 billion of behavioral health facilities and $1.6 billion of post-acute facilities. The forward outlook is limited to an expectation for portfolio cash rents in excess of $1.0 billion in 2027, after the third-quarter asset sales, and includes conservative assumptions for cash-basis tenants including HSA. The principal operating focus is HSA's collections performance and whether asset-sale proceeds continue to support debt reduction.

Management, verbatim

Our results this quarter demonstrate the decisive steps we have taken to strengthen our balance sheet and create greater flexibility to further reduce debt and pursue selective growth opportunities. As healthcare providers around the world seek new solutions to capital challenges, our business model is more important than ever and we are well positioned to create long-term value for our shareholders.

Edward K. Aldag, Jr., Chairman, President and Chief Executive Officer

We are closely monitoring operations at HSA as they navigate continued revenue cycle management challenges that precluded payment of September rent, reducing our NFFO by two cents during the quarter. HSA recently engaged a leading management services provider, Ovation Healthcare, to oversee operations across the portfolio and improve billings and collections.

Edward K. Aldag, Jr., Chairman, President and Chief Executive Officer

Not in the filing

stated, not guessed
  • Gross margin was not reported.
  • Operating income was not reported.
  • Operating cash flow was not reported.
  • Capital expenditures were not reported.
  • Free cash flow was not reported.
  • Share repurchases were not reported.
  • Quarterly sequential comparisons were not reported.
  • Segment revenue disclosures were not reported.
  • Revenue, gross-margin, operating-expense and tax-rate guidance were not reported.
  • Prior outlook was not provided, so no comparison of actual results with prior guidance is available.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Second quarter 2026

AlphAI · Earnings readMPT · Second quarter 2026 · ended June 30, 2026

MPT reports second-quarter net loss of ($3 million) and NFFO of $92 million while announcing a private refinancing transaction for approximately $2.4 billion of secured notes.

→Mixed quarter

NFFO increased from the year-earlier period and the announced refinancing is intended to reduce near-term maturities, but the company remained loss-making on a GAAP basis, carried $9,704,996 of net debt at June 30, 2026, and identified material execution and tenant-related risks.

EPS · non-GAAP
$0.15

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Net lossGAAP($3 million)––
Net loss per shareGAAP($0.01) per share––
Normalized Funds from Operationsnon-GAAP$92M––
Normalized Funds from Operations per sharenon-GAAP$0.15 per share––
Net investment in real estate assetsother10,914,332––
Cash and cash equivalentsother396,558––
Total Assetsother$14.75B––
Debt, netother$9.70B––
Total Liabilitiesother10,247,837––

Amounts quoted below without a unit are in thousands, as in the filing’s tables. Per-share figures are as printed.

Capital returns

  • Paid a regular quarterly dividend of $0.09 per share in July 2026.

What drove it

  • The company cited strong performance trends across its diverse portfolio of global operators and transition tenants ramping rent payments as expected.
  • MPT combined the Lifepoint and Lifepoint Behavioral leases into a single amended master lease, which it said provides increased diversification and an enhanced credit profile.
  • MPT exchanged three Scion properties for one Lifepoint property, generating an approximate $7 million gain.
  • As of June 30, 2026, the portfolio included 373 properties and approximately 38,000 licensed beds leased to or mortgaged by 51 hospital operating companies.
  • MPT reported total assets of approximately $15 billion, including $8.8 billion of general acute facilities, $2.4 billion of behavioral health facilities and $1.7 billion of post-acute facilities.

Concerns

  • The company reported a net loss for the second quarter ended June 30, 2026.
  • The refinancing transaction is expected to close imminently, rather than having closed as of the release date.
  • MPT advanced an additional $50 million for working capital purposes to HSA; $20 million has been repaid and an additional $20 million is expected to be repaid in August.
  • The company identified risks that projected rents may be lower than anticipated or realized later than expected.
  • The company identified risks related to tenant and operator obligations, its ability to monetize investments at full value, and potential effects of changes to Medicaid funding introduced by the OBBBA.

What to watch

  • Closing, proceeds and allocation of proceeds from the approximately $2.4 billion secured-notes refinancing transaction.
  • Receipt of approximately $172 million of expected asset-sale cash proceeds in the third quarter.
  • Receipt of the expected additional $35 million from the Infracore initial public offering later in the third quarter.
  • Repayment timing of the additional $20 million expected from HSA in August.
  • Rent-payment progression from transition tenants and the performance of global operators.
  • The remaining Scion exposure, which MPT stated is limited to one facility.

Balance sheet and cash flow

  • Cash and cash equivalents were 396,558 at June 30, 2026, compared with 540,859 at December 31, 2025.
  • Debt, net was $ 9,704,996 at June 30, 2026, compared with $ 9,697,835 at December 31, 2025.
  • Total Assets were $ 14,747,740 at June 30, 2026, compared with $ 15,001,775 at December 31, 2025.
  • Total Liabilities were 10,247,837 at June 30, 2026, compared with 10,394,526 at December 31, 2025.
  • MPT announced a privately negotiated $2.4 billion refinancing transaction, including discount captured of approximately $123 million, to significantly reduce debt maturing through 2028.
  • MPT agreed to a sale of certain assets that it expects will result in approximately $172 million of cash proceeds in the third quarter.
  • MPT received approximately $100 million in cash proceeds in connection with the initial public offering of Infracore SA and expects an additional $35 million later in the third quarter.

Analysis

MPT reported a second-quarter GAAP net loss of ($3 million), or ($0.01) per share, compared with a net loss of ($98 million), or ($0.16) per share, in the year-earlier period. NFFO was $92 million, or $0.15 per share, compared with $81 million, or $0.14 per share, in the year-earlier period. The release therefore shows improved NFFO and a substantially narrower reported net loss, although the company remained loss-making on a GAAP basis.

Operationally, management pointed to strong performance trends among its global operators and transition tenants ramping rent payments as expected. Portfolio actions included combining the Lifepoint and Lifepoint Behavioral leases into a single amended master lease and exchanging three Scion properties for one Lifepoint property, generating an approximate $7 million gain. MPT stated that its remaining Scion exposure is limited to one facility.

Balance-sheet actions are the central feature of the release. MPT announced a privately negotiated $2.4 billion refinancing transaction, including discount captured of approximately $123 million, which it said significantly reduces debt maturing through 2028. At June 30, 2026, cash and cash equivalents were 396,558 and debt, net was $ 9,704,996. Additional planned liquidity sources include approximately $172 million of expected third-quarter asset-sale proceeds, approximately $100 million received from the Infracore initial public offering, and an expected additional $35 million later in the third quarter.

Capital allocation included payment of a regular quarterly dividend of $0.09 per share in July 2026. The disclosed financing and asset-sale actions remain subject to execution, including the refinancing expected to close imminently. Investor attention should also remain on the HSA working-capital advance, tenant rent realization, the timing and outcome of asset sales and recoveries, and the company's stated risks around tenant solvency, financing access, leverage objectives and potential changes to Medicaid funding.

The company provided no formal forward financial outlook for revenue, expenses, margins, tax rate, earnings or NFFO. Accordingly, the release offers no explicit guided operating benchmark against which to assess the second-quarter result.

Management, verbatim

We continue to take decisive steps to strengthen our balance sheet through our refinancing transactions and strategic asset sales. With strong performance trends across our diverse portfolio of global operators and our transition tenants ramping rent payments as expected, we will continue to evaluate opportunities to fortify our balance sheet while pursuing opportunistic growth.

Edward K. Aldag, Jr., Chairman, President and Chief Executive Officer

Not in the filing

stated, not guessed
  • Total revenue and revenue comparison were not provided in the filing text.
  • Segment revenue, segment year-over-year change and segment quarter-over-quarter change were not provided.
  • GAAP gross margin, operating income, operating expenses, income tax rate and net income reconciliation details were not provided in the filing text.
  • GAAP and non-GAAP operating cash flow and free cash flow were not provided.
  • Share repurchases and repurchase authorization information were not provided.
  • Formal forward guidance for revenue, gross margin, operating expenses, tax rate, earnings or NFFO was not provided.
  • Previous-quarter operating results were not provided.
  • A previous quarterly outlook was not provided.
  • The filing text was truncated during the consolidated balance-sheet presentation; figures after the displayed retained-deficit label were not available.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Questions about MPT earnings dates

When is Medical Properties Trust's next earnings date?
AlphAI has no date for MPT yet. We do not publish estimates, so this page shows a date the day we have one.
Why is there sometimes no date?
AlphAI leaves out estimates. Many sites fill the gap by adding about 91 days to the last report, but that arithmetic is a guess, and a wrong date costs a reader more than a missing one, so we show nothing until a date is set, and a company can still move it. Every quarter already on this page is read straight from the SEC filing: an 8-K item 2.02 for US filers, a 6-K earnings release for foreign private issuers.